Rituximab Therapy in Chronic Childhood Immune Thrombocytopenic Purpura: Is it worth trying?

Letters to the Editor/Technical Note

  • Gonca KESKİNDEMİRCİ, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Müge GÖKÇE, [MD] [PhD]
  • Deniz TUĞCU, [MD] [PhD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Cengiz BAYRAM, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Sevinç GENÇ, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital
  • Gönül AYDOĞAN, [MD] Pediatric Hematology & Oncology Division, Department of Pediatrics, Kanuni Sultan Süleyman Research and Training Hospital

Downloads

Download data is not yet available.
Published
Nov 6, 2017
How to Cite
KESKİNDEMİRCİ, Gonca et al. Rituximab Therapy in Chronic Childhood Immune Thrombocytopenic Purpura: Is it worth trying?. Acta Medica, [S.l.], v. 46, n. 1, p. 85-86, nov. 2017. ISSN 2147-9488. Available at: <https://actamedica.org/index.php/actamedica/article/view/122>. Date accessed: 18 nov. 2017.
Section
Letters to the Editor/Technical Note